does semaglutide make your sugar drop How Works in Weight Loss and Type 2 Diabetes Tirzepatide vs. Semaglutide: What You

Skin, hair and nail rejuvenation thanks to bioactive collagen peptides

When body fat percentage drops below certain thresholds, the brain may temporarily suppress reproductive hormone production, leading to irregular or absent periods

Whether macronutrient ratios, micronutrient concentrations, or bioactive factors in milk change during maternal GLP-1 therapy is an open question

Last year in Clinical Toxicology , emergency medicine doctors reported similar issues in a few cases

What is already known on this topic Glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose cotransporter-2 (SGLT-2) inhibitors reduce the risk of cardiovascular and renal events in patients with type 2 diabetes These drug classes are increasingly used in combination when previous therapy with other antihyperglycaemic drugs fails Whether the combined use of these drug classes results in improved cardiovascular and renal outcomes in the real world setting, compared with the use of either drug class alone, remains unclear What this study adds This population based cohort study aimed at emulating a randomised controlled trial The combined use of a GLP-1 receptor agonist and an SGLT-2 inhibitor was associated with a lower risk of cardiovascular and serious renal events, compared with either drug class alone These findings highlight the potential benefit of combining these two effective drug classes in preventing cardiovascular and renal events in the treatment of type 2 diabetes Data availability statement This study is based on data from the Clinical Practice Research Datalink obtained under license from the UK Medicines and Healthcare products Regulatory Agency

It is important to recognize that sexual dysfunction is common in individuals with obesity and type 2 diabetesthe very populations for whom semaglutide is prescribed